Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
The intestinal barrier is essential in human health and constitutes the interface between the outside and the internal milieu of the body.
-
41/100
Several flavonoids have been recognized as nutraceuticals, and myricetin is a good example.
-
The gut-brain axis is bidirectional, and gut microbiota influence brain disorders including Alzheimer's disease (AD).
-
Insulin is a peptide secreted by the pancreas and plays an important role in the regulation of glucose metabolism in peripheral tissues.
-
Following acute myocardial infarction, re-establishment of coronary perfusion aggravates further injuries in the heart and remote organs including the brain as a consequence of ischemia/reperfusion (I/R) injury.
-
Severe periodontitis is defined by extensive loss of the tooth attachment apparatus.
-
Mucus is integral to gut health and its properties may be affected in neurological disease.
-
Alzheimer's disease (AD) and Parkinson's disease (PD) are neurodegenerative diseases (NDD) characterized by progressive degeneration of the central nervous system, and few medications are available to halt the progression of AD and PD.
-
Akk effectively improved glucose tolerance, intestine barrier dysfunction and dyslipidemia in AD model mice.
-
Flavonoids are a class of natural substances present in plants, fruits, vegetables, wine, bulbs, bark, stems, roots, and tea.
-
Gut microbiome is a community of microorganisms in the gastrointestinal tract.
-
Alzheimer's disease (AD) is the most common form of dementia worldwide, being characterized by the deposition of senile plaques, neurofibrillary tangles (enriched in the amyloid beta (Aβ) peptide and hyperphosphorylated tau (p-tau), respectively) and memory loss.
-
Neuronal insulin resistance is a significant feature of Alzheimer's disease (AD).
-
Our results demonstrate that DA5‐CH has neuroprotective effects in the STZ‐induced animal model and that DA5‐CH has potential to treat neurodegenerative disorders such as AD.
-
There is increasing evidence showing that the dynamic changes in the gut microbiota can alter brain physiology and behavior.
-
Alzheimer's disease (AD) is a neurodegenerative disorder for which there is no cure.
-
Reactive species produced in the cell during normal cellular metabolism can chemically react with cellular biomolecules such as nucleic acids, proteins, and lipids, thereby causing their oxidative modifications leading to alterations in their compositions and potential damage to their cellular activities.
-
Westernized populations are plagued by a plethora of chronic non-infectious degenerative diseases, termed as "civilization diseases", like obesity, diabetes, cardiovascular diseases, cancer, autoimmune diseases, Alzheimer's disease and many more, diseases which are rare or virtually absent in hunter-gatherers and other non-westernized populations.
-
Alzheimer's disease is associated with cerebral accumulation of amyloid-β peptide and hyperphosphorylated tau.
-
Metabolic endotoxemia is a condition in which blood lipopolysaccharide (LPS) levels are elevated, regardless of the presence of obvious infection.
-
Physical activity (PA) has been central in the life of our species for most of its history, and thus shaped our physiology during evolution.
-
The endotoxin hypothesis of neurodegeneration is the hypothesis that endotoxin causes or contributes to neurodegeneration.
-
To understand the role of commensal gut bacteria on the progression of cognitive decline in Alzheimer’s disease via the microbiota-gut-brain axis, we isolated anti-inflammatory Bifidobacterium longum (NK46) from human gut microbiota, which potently inhibited gut microbiota endotoxin production and suppressed NF-κB activation in lipopolysaccharide (LPS)-stimulated BV-2 cells, and examined whether NK46 could simultaneously alleviate gut dysbiosis and cognitive decline in male 5xFAD-transgenic (5XFAD-Tg, 6 months-old) and aged (18 months-old) mice.
-
Animal models provide consistency and validity of research results from in vitro studies or studies with rodents.
-
The kynurenine pathway is important in cellular energy generation and limiting cellular ageing as it degrades about 90% of dietary tryptophan into the essential co-factor NAD + (nicotinamide adenine dinucleotide).
From across this topic
10 of the 1,048 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals
- Anti-Alzheimer Properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's Disease induced Albino Rats
- Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
- New concepts in nutraceuticals as alternative for pharmaceuticals
- Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1
- GLP-1a: Going beyond Traditional Use
- The Gut-Brain Axis in Alzheimer's Disease: Exploring Microbial Influences and Therapeutic Strategies
- Insulin resistance in Alzheimer's disease: The genetics and metabolomics links
- Therapeutic applications of pomegranate (Punica granatum L.): a review
- Promoting Successful Cognitive Aging: A Comprehensive Review